Analysis of cell-type-specific transcriptomes is vital for understanding the biology of tissues and organs in the context of multicellular organisms. In this Protocol Extension, we combine a previously developed cell-type-specific metabolic RNA labeling method (thiouracil (TU) tagging) and a pipeline to detect the labeled transcripts by a novel RNA sequencing (RNA-seq) method, SLAMseq (thiol (SH)-linked alkylation for the metabolic sequencing of RNA). By injecting a uracil analog, 4-thiouracil, into transgenic mice that express cell-type-specific uracil phosphoribosyltransferase (UPRT), an enzyme required for 4-thiouracil incorporation into newly synthesized RNA, only cells expressing UPRT synthesize thiolcontaining RNA. Total RNA isolated from a tissue of interest is then sequenced with SLAMseq, which introduces thymine to cytosine (T>C) conversions at the sites of the incorporated 4-thiouracil. The resulting sequencing reads are then mapped with the T>C-aware alignment software, SLAM-DUNK, which allows mapping of reads containing T>C mismatches. The number of T>C conversions per transcript is further analyzed to identify which transcripts are synthesized in the UPRT-expressing cells. Thus, our method, SLAM-ITseq (SLAMseq in tissue), enables cell-specific transcriptomics without laborious FACS-based cell sorting or biochemical isolation of the labeled transcripts used in TU tagging. In the murine tissues we assessed previously, this method identified~5,000 genes that are expressed in a cell type of interest from the total RNA pool from the tissue. Any laboratory with access to a high-throughput sequencer and high-power computing can adapt this protocol with ease, and the entire pipeline can be completed in <5 d.
Introduction
Life is supported by organ systems, and each organ is formed of numerous highly specialized cells. Thus, it is essential to understand how each cell dynamically alters its gene expression in response to surrounding environmental changes. A simple yet effective way to study cell-specific transcriptomes is to isolate a specific cell type of interest from an intact tissue, extract RNA from the isolated cells, and perform high-throughput gene expression analysis such as RNA-seq. FACS is often used to sort the cells tagged with one or more fluorescent markers from a dissociated tissue. Although this method has been commonly used in many research fields, it has a number of limitations: (i) an extensive optimization is needed to effectively dissociate a tissue to maintain cell viability and transcriptome 1 ; (ii) a cell sorter is not always available, and its run time is often extensive; and (iii) a cell type of interest often consists of a minor proportion of a tissue; hence, use of a large number of animals is sometimes necessary to obtain sufficient cells for transcriptomic analysis.
Thus, a method that does not rely on physical cell-isolation procedures has long been awaited for an easier and more accurate quantification of the transcriptome in a specific cell type.
(T. gondii) can convert 4-thiouracil to 4-thio-UMP 5 . Gay et al. generated 'UPRT mice', which have a transgene that consists of a constitutively active chicken beta-actin promoter, followed by GFP with stop codons, which is flanked by loxP sequences, and a UPRT-coding region downstream of these elements 2 (Fig. 1a) . When this mouse is crossed with a mouse expressing Cre under a cell-typespecific promoter, double-transgenic mice that express UPRT only in Cre-expressing cells can be obtained. Thus, by exposing these double-transgenic mice to 4-thiouracil systemically, only the cells expressing UPRT label RNA, whereas the rest of the cells in the mouse do not. Subsequently, RNA from a tissue of interest is extracted and thiol-specific biotinylation followed by streptavidin pulldown is performed to isolate the thiol-containing RNA. Both this pulled-down fraction and total RNA are quantified by RNA-seq, and the labeled RNA can be identified by finding transcripts that are more enriched in the pulled-down fraction compared to the input fraction.
Although this method, i.e., TU tagging, has already been used in a few studies [6] [7] [8] , it has limitations that prevent its wider adoption. Among them, the use of the biotin-streptavidin-based RNA isolation to identify thiol-containing RNA is the most challenging step. This method requires isolation of thiolcontaining RNA from total RNA, followed by separate sequencing of these two fractions to bioinformatically identify genes that are enriched in the isolated fraction compared to input. However, it is not appropriate to simply apply an existing RNA-seq analysis pipeline to analyze these data, as most differential gene expression analysis packages use a normalization method that assumes that the provided samples have similar proportions of RNA species, apart from the genes that are differentially expressed [9] [10] [11] , which is not the case when comparing pulled-down and input fractions. Although the use of well-designed spike-ins for normalization presents a potential solution 12 , determining an appropriate sample-to-spike-in ratio is not always easy: too much spike-in may result in a low depth of sample RNAs, whereas too-low a spike-in read count would not be sufficient for an accurate normalization. Even if spike-in controls are introduced, it is still difficult to apply TU tagging to cells that consist of either a very minor or a major proportion of a tissue 2 . If the cell number is quite limited, the RNA yield from pull-down eluates would not suffice for a high-throughput transcriptome analysis, whereas if a tissue has a substantial proportion of labeled RNA, it is difficult to identify genes that are enriched in the eluate over input.
Here, we present an enrichment-independent approach to identify cell-type-specific gene expression programs in vivo. Instead of sorting labeled RNA for a separate sequencing library, we use SLAMseq, an RNA-seq method that identifies the thiol-containing base by introducing T>C mismatch at the positions of thiol-containing uridines. In this sequencing method, a carboxyamidomethyl group is added to the thiol group through a nucleophilic substitution reaction with iodoacetamide (IAA), and, in the following reverse transcription step, a guanine (G), instead of an adenine (A), is base-paired to this alkylated uracil (U) resulting in a T>C conversion in the RNA-seq reads (Fig. 1b ) 13, 14 . With this improvement, we now circumvent the tedious and noise-prone biochemical isolation step and overcome the limitation in the range of the proportion of UPRTexpressing cells allowed in a given tissue.
In addition, as mammalian cells can potentially have trace activity in regard to incorporation of exogenous uracil [15] [16] [17] , background 4-thiouracil incorporation into non-UPRT-expressing cells has been a potential problem in previously developed methods. In particular, relying on the enrichment ratio of eluate to flow-through, TU tagging lacks an objective threshold to distinguish the signal from noise (e.g., a minimum fold enrichment that should be considered signal). Therefore, we have redesigned the experiment to include an improved control to account for UPRT-independent RNA labeling and developed a bioinformatic pipeline that quantitatively identifies the labeled RNA based on T>C count (Fig. 1b) .
With this method, which we term SLAM-ITseq, we have successfully identified three different cellspecific transcriptomes in mouse: endothelial cells in brain, epithelial cells in intestine, and adipocytes in white adipose tissue 18 . All these experiments involved little optimization and minimal hands-on time 18 . SLAM-ITseq can be applied in diverse cell types in different tissues with ease.
Applications of the method
In this protocol, we present a method for identifying cell-type-specific polyadenylated (polyA) RNA using a 3′ mRNA sequencing kit from Lexogen. However, SLAM-ITseq can be applied using different RNA-seq library preparation kits, as long as a cDNA synthesis process is involved. In fact, we have also used Illumina's TruSeq total RNA kit, which sequences all the non-ribosomal RNA species that are >200 nt, and the NEXTflex small RNA sequencing kit (Bioo Scientific) for RNA of <200 nt. ) mouse as experimental sample and uprt/0;0/0 as control sample. CA, chicken beta actin promoter; P cell , cell-specific promoter; blue cells, UPRT-expressing cells; wavy lines, RNA; red circles, thiolated uracil; asterisks, carboxyamidomethyl groups; blue lines, adaptors; 'C' in a green circle, T>C conversion induced by 4-thiouracil incorporation.
The two methods have successfully identified cell-type-specific long RNA and small RNA, respectively. Thus, SLAM-ITseq can be applied to study not only polyA RNA but also non-polyA RNAs, including nascent transcripts and small RNA species such as miRNA (W.M., K.G., and E.A.M., data not shown).
Another benefit of using metabolic labeling in transcriptomic analysis is that it provides temporal information about the sequenced RNA by labeling newly synthesized RNAs produced while cells are exposed to 4-thiouracil. This approach differs substantially from classic RNA-seq methods, which can only measure steady-state RNA abundance. A combination of SLAMseq with an auxin-inducible degron system successfully led to discovery of direct targets of the BRD4-MYC pathway 19 . Thus, when combined with a transient perturbation to animals, one can theoretically study dynamic transcriptional changes of a specific cell type in response to stimuli in a unique time-controlled manner.
In addition, this method could potentially be used to discover RNA species that work in a noncell-autonomous manner, as has been hinted at by the small RNA mobility shown in Caenorhabditis elegans and plants 20 . A recent publication of work using 4-thiouracil showed data that are suggestive of potential intercellular transport of miRNA. In this study, miRNAs were found to have a higher occurrence of T>C conversion in non-UPRT-expressing tissue than in tissue from control mice, although it was not possible to identify individual mobile miRNA species, possibly because of the low abundance of mobile miRNAs in the recipient cells 21 .
Comparison with other methods
A clear advantage of SLAM-ITseq over classic FACS-based approaches is that it does not require any cell-isolation steps and could thus be used to study cells that are difficult to isolate from a tissue or that are vulnerable to any chemical and/or physical stimuli. It should, however, be noted that SLAMITseq relies on the specificity of a single promoter that drives Cre expression to achieve cell-typespecific RNA labeling. Hence, where identity of cells depends on expression of multiple genes, FACS might be more suitable (e.g., some subtypes of immune cells can be distinguished only on the basis of the expression of multiple surface markers). Another FACS-independent, yet pull-down-dependent, approach to the study of cell-specific RNA is to overexpress a tagged RNA-binding protein in a specific cell type to co-purify the RNA that is bound to it. By using different RNA-binding proteins to 'fish out' RNAs, one can study different cellspecific properties: mRNAs being translated can be found with a tagged ribosome pull-down 22 ; alternative polyadenylation events can be studied with polyA-binding protein (PABP) 23 . These methods and SLAM-ITseq are complementary to each other and enable investigation of RNA dynamics from different perspectives.
There are also alternative RNA-seq-based methods for detecting thiol-containing RNA: thiouridine-to-cytidine sequencing (TUC-seq) 24 and TimeLapse-seq 25 . Instead of introducing T>C conversion during the reverse transcription step as in SLAMseq, these two methods directly convert 4-thiouridine to cytidine in RNA by using osmium tetroxide (OsO 4 ) and ammonium in TUC-seq, and 2,2,2-trifluoroethylamine (TFEA) and sodium periodate (NaIO 4 ) in TimeLapse-seq. SLAMseq and TUC-seq have a comparable conversion rate (>90%) per 4-thiouridine introduced. TimeLapseseq provides only semi-quantitative data about its conversion rate with a restriction digestion assay, showing it has an~80% conversion rate per 4-thiouridine (also reviewed in ref. 26 ). Both TUC-seq and TimeLapse-seq could potentially be used instead of SLAMseq to determine labeled transcripts, depending on one's experimental aim (e.g., if direct RNA-seq by a Nanopore sequencer is desired). A direct comparison using the same starting material might be needed to determine which method is the most sensitive and how critical the difference is.
Limitations

Sensitivity
Although we have confirmed sufficient labeling of RNA to identify cell-type-specific transcripts in endothelial cells, which represent a minor proportion (~5%) of brain cells 18 , SLAM-ITseq might not be sensitive enough to detect transcripts from an even less abundant cell population. The sensitivity could be improved by increasing the sequencing depth, but that comes with an increased sequencing cost per sample.
A potential workaround is to enrich for the labeled RNA by the biotin-streptavidin isolation method, followed by performing SLAMseq on the purified RNA to identify which pulled-down RNA contains the thiol group. Although this particular combination has not yet been tested, TimeLapse-seq has used this strategy (TT-TimeLapse-seq) and detected more reads originating from transient transcripts (i.e., pre-mRNA) from cells exposed to 4-thiouridine for a limited time 25 . The benefits of combining these two methods are: (i) the labeled RNA is more deeply sequenced with unlabeled RNA removed, which might increase the sensitivity, and (ii) the unlabeled RNA that is non-specifically pulled down in the purification step can be identified based on the number of T>C conversions in the reads. This combined method, however, has not been assessed for its recovery rate (i.e., how much labeled RNA is lost) and still retains all the drawbacks of using a purification step discussed in the 'Development of the protocol' section, such as the requirement of spike-ins for downstream analysis; therefore, a thorough comparison would be needed to deem this approach superior to increasing sequencing depth.
Also, accessibility for circulating 4-thiouracil in the blood might be limited for certain cell types (e.g., neurons), which may have lower labeling levels. Increasing the dose of 4-thiouracil could potentially have negative impacts on animal well-being; hence, too much deviation from the reported dose is not recommended.
Effects on RNA metabolism
As our knowledge about the effects of RNA modifications on the biochemical properties of RNA is still limited, it is hard to predict if 4-thiouracil-containing RNA retains the same properties as unmodified RNA. In an in vitro experiment, it was reported that a high dose (>50 µM) of 4-thiouridine inhibits translation by inhibiting rRNA synthesis 27 . Although the concentration of 4-thiouracil that the cells are exposed to in vivo in SLAM-ITseq experiments is diluted in animal circulation, it could potentially affect RNA metabolism. Thus, we recommend routinely comparing the transcriptomes of Cre + and Cre − animals. If the expression levels of the two highly and positively correlate (e.g., Spearman's correlation coefficient >0.9), it suggests that the 4-thiouracil incorporation at the given concentration has little impact on RNA metabolism.
Leaky Cre expression
As has been reported in several publications, the expression of Cre driven by certain promoters is not always highly specific and, in some cases, is stochastic 28 . Thus, minor levels of non-specific expression of Cre and UPRT in a given tissue can occur, although this issue is relevant to all methods that depend on cell-type specificity of a promoter. It is strongly advisable to use a well-studied Cre line or to conduct additional validations of the specificity of the Cre expression that are tailored to one's specific experimental design. Because the transgenic UPRT expressed in the mouse has a hemagglutinin (HA) tag attached, its cellular expression pattern can be validated by a standard immunohistochemistry method against HA 2 .
Experimental design
Mouse breeding UPRT mice and Cre mice are crossed to generate the double-transgenic mouse UPRT transgene and the Cre transgene under a cell-type-specific promoter (Cre + mice) (Fig. 1b) . To control for UPRTindependent 4-thiouracil incorporation, mice with only the UPRT transgene (Cre − ) should also be generated. For this purpose, a cross between homozygous UPRT mice (uprt/uprt) and hemizygous Cre mice (cre/0) is recommended, as a 1:1 ratio of Cre + and Cre − mice can be obtained in the same litter. A minimum of two mice for each condition are necessary to perform the statistical test used to identify labeled genes in the downstream bioinformatic analysis. We have used both male and female C57BL/6NTac mice aged between 8 and 10 weeks.
4-Thiouracil administration Both Cre
+ and Cre − animals should be given the same 4-thiouracil solution in a consistent way. Although in this protocol we describe an administration method involving intraperitoneal injection 2, 3, 18 , we have confirmed that subcutaneous injection also works, with the same labeling efficiency (i.e., overall T>C conversion rate). We recommend allowing enough time to collect tissues from each mouse between injections so that each mouse is exposed to the solution for approximately the same duration upon culling. Also, the duration of exposure to 4-thiouracil can be adjusted according to one's experimental aims. Although we have confirmed that >3,000 mRNAs were significantly labeled (false-discovery rate (FDR) <0.05, beta-binomial test) in three different cell types (endothelial cells, intestinal epithelial cells, and adipocytes) by 4-h exposure to 4-thiouracil, a longer exposure time can be used when studying a cell that is known to be less transcriptionally active or RNAs that have a longer turnover time.
Tissue collection
Care must be taken to avoid RNA degradation when collecting tissues. Although we have used RNAlater for tissue preservation, any other standard tissue storage methods that are compatible with a subsequent RNA extraction step can be used (e.g., snap freezing).
RNA extraction
Although we have used an organic extraction method using TRIsure, other standard RNA extraction methods should be applicable. To avoid oxidation of the thiol group, it is important to add DTT to a final concentration of 100 µM when performing the isopropanol precipitation step and to dissolve the obtained RNA pellet in 1 mM DTT solution.
An RNA quality check with a Bioanalyzer RNA chip or equivalent should be performed. Although the QuantSeq kit is compatible with degraded RNA, all the samples should have a similar RNA integrity number (RIN) for consistent results.
To confirm the transgene expression, we recommend performing reverse transcription, followed by quantitative PCR (RT-qPCR) against UPRT on both Cre + and Cre − mice (Box 1).
IAA treatment
The IAA solution must be made freshly just before a reaction is performed. We recommend including a reaction that alkylates pure 4-thiouracil solution as a positive control and to confirm successful alkylation by a spectrophotometer (details are provided in Box 2).
RNA-seq library preparation
We have followed the standard protocol of the QuantSeq 3′ mRNA-Seq Library Prep Kit FWD for Illumina. Before performing a sequencing run, a library quality check with a Bioanalyzer highsensitivity chip or equivalent should be performed. We have multiplexed up to six libraries per lane on a flow cell.
Bioinformatic analysis
After a set of basic quality checks of the reads are performed with FastQC, T>C-aware alignment, followed by T>C counting, is conducted by the software, SLAM-DUNK 29 (http://t-neumann.github.io/ slamdunk/), which was specifically developed for SLAMseq data analyses. Although various analyses could be performed on the T>C count table generated by SLAM-DUNK (Step 52), depending on the purpose of an experiment, we have used beta-binomial regression 30 to identify which genes have significantly higher T>C conversion rates (FDR <0.05) in Cre + as compared with Cre − mice.
Expertise needed to implement the protocol As this protocol involves generation of transgenic mice, an appropriate mouse facility is needed to maintain a small number of mice. Either intraperitoneal or subcutaneous injection must be performed by a person who is able to inject a small volume of solution steadily without injuring the surrounding organs. SLAMseq data analysis with SLAM-DUNK requires a high-performance computing system with a Linux operating system. Although basic command-line usage is required to run SLAM-DUNK pipelines, and, for the downstream analyses (Steps 55-62), knowledge of a language such as R or Python is beneficial, Lexogen now offers a pipeline on a web server for SLAMseq analyses (BlueBee; http://www.bluebee.com/lexogen/). Hence, basic analyses (e.g., calculating the T>C conversion rate in each gene) can be performed with little or no programming skill.
Materials Biological materials
! CAUTION All mouse procedures must be conducted at an appropriate animal facility, and both governmental and institutional laws and guidelines must be followed. All the animal experiments involved in the development of this protocol were conducted in accordance with UK Home Office regulations and the UK Animals (Scientific Procedures) Act of 1986 under a UK Home Office license that approved this work (PF8733E07), which was reviewed regularly by the Wellcome Sanger Institute Animal Welfare and Ethical Review Body.
• B6;D2-Tg(CAG-GFP,-Uprt)985Cdoe/J (UPRT mice; The Jackson Laboratory, stock no. 021469) • Cre driver line (Cre mice), e.g., B6.Cg-Tg(Tek-cre)1Ywa/J (The Jackson Laboratory, stock no. 008863)
Reagents
• 4-Thiouracil (Sigma-Aldrich, cat. no. 440736) ! CAUTION 4-Thiouracil is harmful upon inhalation or contact with skin, and if swallowed. Gloves and a lab coat must be worn when handling it.
• Dimethyl sulfoxide (DMSO; Sigma-Aldrich, cat. no. D1435-500ML) • 
Equipment
• Filtered pipette tips (STARLAB, TipOne, cat. nos. S1120-3810, S1120-1810, S1120-8810 and S1126-7810) c CRITICAL To prevent contamination by RNase present in the environment, filtered tips should be used when handling a solution containing RNA.
• DNase-free microcentrifuge tubes (1.5 and 2 ml; Eppendorf, cat. nos. 0030108051 and 0030108078) • 8-Strip PCR tubes and caps (0.2 ml; STARLAB, cat. nos. I1402-3500, I1400-0900) c CRITICAL To avoid RNA degradation, any equipment that directly contacts the RNA should be nuclease free.
• Syringes ( • RStudio (https://www.rstudio.com/)
Reagent setup
4-Thiouracil solution
Prepare a 200-mg/ml stock solution in DMSO, which can be stored at −20°C for 1 year. On the day of injection, dissolve the stock solution in corn oil at a 1:4 ratio (50-mg/ml final 4-thiouracil concentration). Shake vigorously just before injection to achieve homogeneity. As 4-thiouracil is UV sensitive, exposure to light should be kept minimal.
80% (vol/vol) EtOH
Always dilute absolute EtOH in nuclease-free water immediately before use.
Glycogen solution (20 mg/ml) Dissolve glycogen in nuclease-free water to make a 20-mg/ml solution. The solution should be divided into aliquots in sterile tubes (~100 µl per tube) to avoid excessive freeze-thaw cycles. This solution can be stored at −20°C for 1 year.
dNTP mix (10 mM) Mix one volume of 100 mM dATP, dTTP, dGTP, and dCTP solution each and add 6 volumes of nuclease-free water. The solution should be divided into aliquots in sterile tubes (~100 µl per tube) to avoid excessive freeze-thaw cycles. The mix can be stored at −20°C for 1 year.
DTT Prepare a 1 M stock solution in nuclease-free water and store it at −20°C for up to 1 year. The solution should be divided into aliquots in sterile tubes (~100 µl per tube) to avoid excess freeze-thaw cycles. On the day of use, dissolve the stock solution in nuclease-free water to make either 100 mM or 1 mM solution for reactions.
IAA
Freshly prepare a 100 mM solution in absolute EtOH on the day of use.
500 mM sodium phosphate (pH 8) Dissolve 6.00 g of sodium phosphate, monobasic, in 100 ml of ultrapure water. Autoclave the solution and adjust its pH, using sodium hydroxide and hydrochloric acid. Alternatively, use sodium phosphate, dibasic, to adjust the pH of the buffer 32 . The solution can be stored at room temperature (20°C) for 1 year. 1 Prepare a 50-mg/ml 4-thiouracil solution in DMSO and corn oil (see 'Reagent setup' for further details). Because a needle and a syringe have dead-space (~100 µl), we recommend preparing an excess amount of the solution (e.g., 300 µl × 7 for six adult mice). ! CAUTION 4-Thiouracil is harmful upon inhalation or contact with skin, and if swallowed. Gloves and a lab coat must be worn when handling it. c CRITICAL STEP 4-Thiouracil is UV sensitive; thus its exposure to UV should be limited. We advise covering the tube with foil to prevent the solution from being exposed to light. ? TROUBLESHOOTING 2 Weigh the mice and calculate the volume of 4-thiouracil solution to inject to achieve a dose of 400 mg/kg of body weight (i.e., 200 µl of 4-thiouracil solution for a 25-g mouse). c CRITICAL STEP Always start with at least two Cre + and Cre − mice to statistically identify celltype-specific transcripts. 3 Inject the 4-thiouracil solution intraperitoneally, using a 25-gauge × 5/8-inch needle. c CRITICAL STEP Shake the solution vigorously just before each injection to homogenize the solution, which can easily become phase-separated. c CRITICAL STEP Allow enough time between injections (~10 min) into successive mice so that each mouse is exposed to the solution for the same duration at the time of culling. 4 Return the mouse cages to the original holding space and allow a minimum of 4 h exposure to the solution. c CRITICAL STEP Longer exposure time and repeated injections might increase the labeling level of RNA, especially to RNAs with a longer half-life (e.g., miRNA). We have confirmed that two more additional injections every 24 h increases the labeling level of miRNAs in the liver.
NATURE PROTOCOLS
PROTOCOL EXTENSION
Tissue collection • Timing 2 h
5 Prepare 1.5-ml tubes to collect tissues and fill the tubes with 1 ml of RNAlater. c CRITICAL STEP Confirm that your tissue of interest is compatible with RNAlater preservation. If not, other methods, such as snap freezing, can be used. 6 Cull the mice one by one, dissect out the tissues of interest and submerge them in RNAlater. c CRITICAL STEP Cut the tissues into pieces such that the thickness of any one dimension does not exceed 5 mm to ensure that the RNAlater spreads effectively. j PAUSE POINT Tissues in RNAlater can be stored at 4°C for 1 month. Longer storage can be achieved at ≤−20°C after storage at 4°C overnight to allow the RNAlater to diffuse into the cells.
RNA extraction • Timing 4 h
7 Dispense a 7-mm bead in a 2-ml tube, using a TissueLyser bead dispenser. 8 Remove a piece of tissue from the RNAlater with forceps and remove the residual RNAlater using a clean piece of paper (e.g., a Kimwipe). 9 Cut the tissue into a small piece so it does not exceed 100 mg and put the piece into the 2-ml tube prepared in Step 7. The remainder of the tissue can be stored in RNAlater at 4°C for up to 1 month. c CRITICAL STEP The maximum weight of tissue allowed can vary depending on the type of tissue. Refer to the TRIsure instruction manual to adjust it accordingly. 10 Dispense 1 ml of TRIsure into the 2-ml tube, load the tubes into a TissueLyser, and run the TissueLyser, following the manufacturer's instruction. Incubate at room temperature for 5 min after the homogenization. ! CAUTION TRIsure is toxic and corrosive. Always handle it while wearing gloves, a lab coat, and protective glasses in a chemical fume hood. c CRITICAL STEP From this step up to Step 28, the solution containing thiolated RNA should be protected from light by covering the tube(s) with foil as much as possible, because the thiol group is UV sensitive. 11 Transfer the solution to a new 1.5-ml tube and add 200 µl of the chloroform-isoamyl alcohol mixture. ! CAUTION Chloroform is toxic if swallowed and a potential carcinogen. Always handle it while wearing gloves, a lab coat, and protective glasses in a chemical fume hood. 12 Shake the tube vigorously for 15 s and incubate it for 3 min at room temperature. 13 Centrifuge the tube at 12,000g for 15 min at 4°C.
14 Carefully transfer the upper aqueous phase to a new 1.5-ml tube. 15 Add 1 µl of glycogen solution (20 mg/ml), 1 µl of 100 mM DTT, and 500 µl of cold isopropanol.
Mix vigorously. ! CAUTION DTT is harmful if swallowed and causes skin irritation upon direct contact. Gloves and a lab coat must be worn when handling it. c CRITICAL STEP Always add freshly prepared DTT solution to prevent oxidation of the thiol group introduced into the RNA. 16 Incubate the tube at −20°C for at least 2 h. j PAUSE POINT Alternatively, the incubation can be extended indefinitely. 17 Centrifuge the tube at 12,000g for 30 min at 4°C. 18 Remove the supernatant and wash the pellet with 1 ml of cold 80% (vol/vol) EtOH. 19 Centrifuge the tube at 12,000g for 10 min at 4°C. 20 Remove the supernatant and air-dry the pellet for 4 min at room temperature. 36 Follow the instructions of the QuantSeq 3′ mRNA-Seq Library Prep Kit to prepare RNA-seq libraries. Use different indices for different samples for multiplexing. c CRITICAL STEP Although the minimum total RNA input for the QuantSeq kit is 500 pg, it is recommended to use a higher amount of starting RNA to have more RNA molecules sequenced for a sensitive detection of labeled transcripts. We routinely start with~500 ng of total RNA. Box 
Procedure
1 To confirm that alkylation has been carried out successfully in Steps 26-28, we strongly recommend performing the following reaction, using 4-thiouracil instead of RNA, in parallel as a positive control and checking its absorbance peak. You should also prepare an identical sample in which the IAA is replaced with EtOH (see table below). Dilute the resulting solutions 1:10 and load 2 µl of each for a spectrophotometer assay. Successful alkylation can be confirmed with the shift of an absorbance peak from 330-335 nm (4-thiouracil) to 295 nm (alkylated 4-thiouracil) on a spectrophotometer (e.g., UV-Vis mode on a NanoDrop spectrophotometer) (Fig. 2) . ? TROUBLESHOOTING 37 Check the library quality with a High Sensitivity DNA Kit. A successful library should have a single peak at the~200-to 300-bp region.
Component
High-throughput sequencing • Timing 1 d
38 Multiplex an equimolar amount of each library and perform high-throughput sequencing. j PAUSE POINT RNA-seq libraries can be stored at 4°C for a week or at −20°C indefinitely.
Software installation • Timing 15 min
39 Install the Miniconda downloader by typing the following command into a console window.
wget https://repo.continuum.io/miniconda/Miniconda3-latest-Linux-x86_ 64.sh 40 Install Miniconda. Run the command below and follow the prompts on the screen to complete the installation.
bash Miniconda3-latest-Linux-x86_64.sh 41 Set up channels to where the necessary software packages are located for software installation step (Step 42).
conda config --add channels defaults conda config --add channels conda-forge conda config --add channels bioconda 42 Install the software packages required for the analyses into a custom environment.
conda create --name slamseq slamdunk fastqc multiqc 52 Run SLAM-DUNK on a high-performance computing system, using the command below. The details of the parameters are outlined at http://t-neumann.github.io/slamdunk/docs.html.
slamdunk all -r path/to/fasta -b path/to/bed -t 5 -5 12 -n 100 -m -mv 0. install.packages(c("dplyr", "tidyr", "ibb")) library("dplyr") library("dplyr") library("dplyr") 57 Read all the count tables and combine them into one data frame. ls <-list.files(pattern = "_tcount.tsv") df <-do.call(rbind, Map("cbind", lapply(ls, read.delim, skip = 2, header = T), sample = gsub("//..*","",ls))) 58 Reshape the data frame for the ibb function to perform the beta-binomial test.
dfsprd <-df %>% select(sample, Name, CoverageOnTs, ConversionsOnTs) %>% gather(variable, value, CoverageOnTs, ConversionsOnTs) %>% unite(var, variable, sample) %>% group_by(var) %>% mutate(id = 1:n()) %>% spread (var, value) 59 Remove genes with no T coverage in any sample.
dfexp <-dfsprd[apply(dfsprd %>% select(starts_with("CoverageOnTs")), 1, function(z) !any(z == 0)),] 60 Define the variables needed for the ibb run. Group variables must be specified in the order they appear in the 'dfexp' column.
dftc <-dfexp %>% select(starts_with("ConversionsOnTs")) dftotal <-dfexp %>% select(starts_with("CoverageOnTs")) group <-c("cr","wt","cr","cr","cr","wt","wt") bbtest <-bb.test(dftc, dftotal, group, n.threads = 0)
62 Write a table with P values and FDR calculated by the beta-binomial test.
dfexp$pval <-bbtest$p.value adj <-dfexp %>% mutate(BH = p.adjust(pval, method = "BH")) write.table(adj, file = "ibb.txt", sep = "/t", quote = F)
Troubleshooting
Troubleshooting advice can be found in Table 2 .
Timing
Steps 
Anticipated results
RNA obtained from tissues through this RNA extraction method should have an RIN of 8 or higher. Lower RIN value could mean mishandling of samples when collecting tissues, but some tissues generally have a relatively lower RIN value compared with the other tissues (e.g., intestine).
In the RT-qPCR results, we observed a difference in cycle threshold (ΔCt; UPRT−Hprt (hypoxanthine-guanine phosphoribosyltransferase)) of 3-4 in Cre − tissues. UPRT expression in different Cre + mice is summarized in Table 3 , although it should be noted that this relative expression depends on the proportion of Cre-expressing cells in the tissue and the activity of the promoter that drives Cre expression. The IAA treatment step should have a minimal impact on RNA quantity and quality. By following the QuantSeq kit protocol, each resulting library should be >10 nM in concentration and have a single peak at the~250-to 300-bp region in the Bioanalyzer results. When high-throughput sequencing is performed by multiplexing six QuantSeq libraries per lane, each library should yield~50 million reads, and 200-300 median mapped reads per gene, which can be confirmed in the SLAM-DUNK output. Although the T>C conversion rate might vary depending on the ratio of Cre-expressing cells to the rest of the cells in a tissue from which RNA is extracted, we have observed median T>C conversion rates of 0.1% (endothelial cells in brain) and 1% (epithelial cells in intestine) 18 . Typical results from MultiQC reports about conversion rate per 3′ UTR can be found at https://mts-np.nature.com/np_files/2019/03/14/00011474/02/11474_2_data_set_174642_ pbf3zh.html. These are representative MultiQC results from Tie2-Cre; UPRT transgenic mice (endothelial-specific labeling). A beta-binomial test identified~5,000 genes that are expressed in endothelial cells in mouse brain (Fig. 3) .
Reporting Summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article. n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Software and code
Policy information about availability of computer code
Data collection
No software was used to collect data.
Data analysis
All the softwares used for data analysis were listed in the Software section in the manuscript.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability All studies must disclose on these points even when the disclosure is negative.
Sample size
No statistical methods to pre-determine the sample size were used since there is no data available for power analysis. Standard sample size of 2-4 were used for SLAMseq analysis and it is known that beta-binomial test can be performed with this sample size.
Data exclusions For labelled transcripts identification, genes did not have any T sequenced were excluded from the data, since it is not possible to perform beta-binomial test on them.
Replication
Biological replicates were used as described in the methods section.
Randomization Since comparisons were made based on the genotype of the mice, no randomisaion was involved. 
